- Home
- AMLX vs ORGO Comparison
AMLX vs ORGO Comparison
Compare AMLX & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- ORGO
- Stock Information
- Founded
- AMLX 2014
- ORGO 1985
- Country
- AMLX United States
- ORGO United States
- Employees
- AMLX N/A
- ORGO N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- AMLX Health Care
- ORGO Health Care
- Exchange
- AMLX Nasdaq
- ORGO Nasdaq
- Market Cap
- AMLX 481.9M
- ORGO 474.6M
- IPO Year
- AMLX 2022
- ORGO N/A
- Fundamental
- Price
- AMLX $4.05
- ORGO $3.05
- Analyst Decision
- AMLX Buy
- ORGO Strong Buy
- Analyst Count
- AMLX 7
- ORGO 3
- Target Price
- AMLX $7.60
- ORGO $5.33
- AVG Volume (30 Days)
- AMLX 786.1K
- ORGO 1.1M
- Earning Date
- AMLX 11-07-2024
- ORGO 11-12-2024
- Dividend Yield
- AMLX N/A
- ORGO N/A
- EPS Growth
- AMLX N/A
- ORGO N/A
- EPS
- AMLX N/A
- ORGO N/A
- Revenue
- AMLX $196,485,000.00
- ORGO $455,038,000.00
- Revenue This Year
- AMLX N/A
- ORGO $9.65
- Revenue Next Year
- AMLX N/A
- ORGO $1.57
- P/E Ratio
- AMLX N/A
- ORGO N/A
- Revenue Growth
- AMLX N/A
- ORGO 1.34
- 52 Week Low
- AMLX $1.58
- ORGO $2.17
- 52 Week High
- AMLX $19.95
- ORGO $4.71
- Technical
- Relative Strength Index (RSI)
- AMLX 36.50
- ORGO 35.65
- Support Level
- AMLX $3.78
- ORGO $3.28
- Resistance Level
- AMLX $4.40
- ORGO $3.68
- Average True Range (ATR)
- AMLX 0.30
- ORGO 0.23
- MACD
- AMLX -0.12
- ORGO -0.10
- Stochastic Oscillator
- AMLX 15.52
- ORGO 0.00
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.